Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6129952 | Clinical Microbiology and Infection | 2014 | 8 Pages |
Abstract
Clostridium difficile infection is a leading cause of antibiotic-related and healthcare-related diarrhoea. In the past decade, faecal microbiota transplantation or transfer has attracted increasing interest as an effective treatment strategy for severe recurrent C. difficile infection, with a global success rate of >80%. However, experience with this procedure is limited by a lack of randomized trials supporting its efficacy and the lack of standardization of the procedure. This review will address the practical aspects of the protocol.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
N. Kapel, M. Thomas, O. Corcos, C. Mayeur, L. Barbot-Trystram, Y. Bouhnik, F. Joly,